Metabolic Score for Insulin Resistance

The Metabolic Score for Insulin Resistance (METS-IR) is a metabolic index developed with the aim to quantify peripheral insulin sensitivity in humans; it was first described under the name METS-IR by Bello-Chavolla et al. in 2018.^[1][2] It was developed by the Metabolic Research Disease Unit at the Instituto Nacional de Ciencias Médicas Salvador Zubirán^[3] and validated against the euglycemic hyperinsulinemic clamp and the frequently-sampled intravenous glucose tolerance test in Mexican population.^[1] It is a non-insulin-based alternative to insulin-based methods to quantify peripheral insulin sensitivity and an alternative to SPINA Carb, the Homeostatic Model Assessment (HOMA-IR) and the quantitative insulin sensitivity check index (QUICKI). METS-IR is currently validated for its use to assess cardio-metabolic risk in Latino population.^[1]

Derivation and validation

METS-IR was generated using

METS-IR was compared against other non-insulin-based methods to approximate insulin sensitivity including the Triglyceride-Glucose index (TyG),[6] the triglyceride to HDL-C ratio,^[7] and the TyG-BMI index,^[8] yielding a higher correlation and area under the receiving operating characteristic curve compared to these other measures.^[1] When assessing its utility for identifying metabolic syndrome in Chinese subjects, Yu et al. suggested that the TyG and TG/HDL-C indexes had superior performance in their population owing to ethnic-specific variations in body composition.^[9] Given the role of ethnicity in modifying the performance of insulin sensitivity fasting-based indexes, further evaluations in different populations are required to establish performance of non-insulin-based methods.^[10]

See also

• Insulin resistance
• Homeostatic model assessment
• SPINA-GBeta
• SPINA-GR
• Disposition index
• Quantitative insulin sensitivity check index
• Diabetes mellitus
• Diabetes management

References